News
BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...
2025 is shaping up to be a game-changer for AI in marketing. Join us on May 27 for a hybrid event, featuring a panel discussion on how AI is impacting life sciences marketing. This event is structured ...
The Translational Research Grant (TRG) program funds projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions. The ...
Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate ...
Following a regulatory setback last year, Satsuma Pharmaceuticals Inc. has won approval for its nasal powder migraine ...
Join Women in BIO and the Women's Empowering Network at Labcorp on May 29 to elevate your professional profile and gain confidence in salary negotiation. Whether you're actively job searching or ...
Join Innovate Carolina’s Office of Technology Commercialization for its 2025 Celebration of Inventorship, an evening dedicated to recognizing UNC’s distinguished inventors. This event will feature ...
Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...
Over the past year my colleague Nandini Mendu, Ph.D., senior director, agriculture sector development, has been working on a strategic project looking into North Carolina’s animal health and nutrition ...
This practical, one-hour virtual session is designed to help North Carolina life sciences companies understand the basic steps of obtaining CE Mark certification. Regulatory experts from North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results